Sweden

Cellcolabs snaps $12M to scale global Access to Next-Generation Stem Cell Therapies
Swedish biotech startup Cellcolabs has secured $12 million in primary funding from Titian Capital’s life sciences platform, bringing its total raised to $37 million.

The best Articles in our Network